Sirtuin 1 inhibits TNF-α-mediated osteoclastogenesis of bone marrow-derived macrophages through both ROS generation...

Area of Science:

• Molecular biology
• Cell biology
• Bone biology

Background:

• Sirtuin 1 (SIRT1) is implicated in bone resorption in vivo.
• The role of SIRT1 in osteoclastogenesis in vitro remains unclear.

Purpose of the Study:

• To investigate the effects and underlying mechanisms of SIRT1 on osteoclast differentiation in vitro.
• To elucidate the role of SIRT1 in regulating osteoclastogenesis in mouse bone marrow-derived macrophages (BMMs).

Main Methods:

• RANKL-induced osteoclastogenesis in BMMs.
• Manipulation of SIRT1 levels using activators (resveratrol), inhibitors (EX-527), overexpression, and silencing.
• Assessment of osteoclast differentiation markers (TRAP staining, gene expression).
• Analysis of tumor necrosis factor-alpha (TNF-α) levels.
• Investigation of reactive oxygen species (ROS) production and TRPV1 channel activation.

Main Results:

• SIRT1 downregulation was observed during RANKL-induced osteoclastogenesis.
• SIRT1 activation (resveratrol, overexpression) inhibited osteoclastogenesis, while inhibition (EX-527, silencing) promoted it.
• SIRT1 modulated TNF-α levels, which in turn affected osteoclastogenesis.
• TNF-α silencing blocked osteoclastogenesis promoted by SIRT1 depletion.
• SIRT1 inhibition of ROS generation and TRPV1 channel activation was mediated by TNF-α.

Conclusions:

• SIRT1 directly inhibits osteoclast differentiation in vitro.
• The mechanism involves the downregulation of TNF-α, leading to reduced ROS production and TRPV1 channel activation.
• SIRT1 plays a protective role against excessive osteoclast activity and potential bone loss.